The Week in Review: October 27 – November 4, 2017

Friday, November 4, 2017 News Recap: Access to Treatment Hepatitis C could be eliminated in Canada, but drug prices, screening barriers stand in the way – Most of the 70 million patients infected with hepatitis C worldwide could be cured for $50 US each Many countries — including Canada — have committed to a global goal of eliminating hepatitis C by 2030. But new data released at the summit in Brazil shows that only nine countries are on track to me...

Elevated HBV Marker Increases Risk for Liver Cirrhosis

For hepatitis B virus (HBV) carriers, hepatitis B virus core-related antigen (HBcrAg) levels are associated with progression to cirrhosis, according to a study published online in the Journal of Gastroenterology and Hepatology. Toshifumi Tada, MD from Ogaki Municipal Hospital in Japan, and colleagues examined the predictive impact of HBV markers on progression to cirrhosis in HBV carriers. "Elevated HBcrAg levels in HBV carriers increases the risk for